Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Claros Mortgage Trust, Inc.Claros Mortgage Trust Reports Significant Revenue Decline and Net Loss in Q3 2025
Context Therapeutics Inc.Context Therapeutics Reports $9.7 Million Net Loss in Q3 2025, Zero Revenue
CareTrust REIT, Inc.CareTrust REIT Reports 71% Revenue Growth to $132.4 Million in Q3 2025
DYNAVAX TECHNOLOGIES CORPDynavax Technologies Reports 17.7% Revenue Growth in Q3 2025
TRANSCAT INCTranscat Reports 21.3% Revenue Growth in Q2 Fiscal 2026, Net Income Declines
Payoneer Global Inc.Payoneer Reports 9% Revenue Growth to $270.9 Million in Q3 2025
Grocery Outlet Holding Corp.Grocery Outlet Reports 5.4% Sales Increase and Net Income Decline in Q3 Fiscal 2025
FIRST UNITED CORP/MD/First United Corporation Reports $6.9 Million Net Income for Q3 2025
TEVA PHARMACEUTICAL INDUSTRIES LTDTeva Pharmaceutical Reports $4.48 Billion Revenue in Q3 2025, 3% Year-Over-Year Increase
Evercore Inc.Evercore Inc. Reports 42% Revenue Growth to $1.046 Billion in Latest Quarter
STIFEL FINANCIAL CORPStifel Financial Corp. Reports 16.7% Revenue Growth and 35.4% Increase in Net Income for Q3 2025
Aquestive Therapeutics, Inc.Aquestive Therapeutics Reports Q3 2025 Revenue Decline and Increased Net Loss
GENELUX CorpGenelux Corporation Reports $7.95 Million Net Loss in Q3 2025
Flowco Holdings Inc.Flowco Holdings Inc. Reports Q3 2025 Financial Results with Revenue of $176.9 Million
Chiron Real Estate Inc.Global Medical REIT Reports $5.1 Million Net Loss in Q3 2025 Amid Increased Revenue
ALIGN TECHNOLOGY INCAlign Technology Reports Q3 2025 Financial Results with Revenue Increase but Declining Net Income
ARVINAS, INC.Arvinas Reports Significant Revenue Decline in Q3 2025, Net Loss Improves
ZIMMER BIOMET HOLDINGS, INC.Zimmer Biomet Reports 9.7% Revenue Growth in Q3 2025, Net Earnings Decline
STAAR SURGICAL COSTAAR Surgical Reports Q3 2025 Financial Results with Net Income Decline and Merger Plans
Dyne Therapeutics, Inc.Dyne Therapeutics Reports $334.3 Million Net Loss and Increased R&D Expenses for Nine Months Ended September 30, 2025
Fortrea Holdings Inc.Fortrea Holdings Reports 3.9% Revenue Growth in Q3 2025, Operating Loss Improves
FORWARD AIR CORPForward Air Reports Decrease in Operating Revenue and Net Loss in Q3 2025
Adicet Bio, Inc.Adicet Bio Reports $26.9 Million Net Loss in Q3 2025, Progresses with Clinical Trials
Vera Therapeutics, Inc.Vera Therapeutics Reports $80.3 Million Net Loss in Q3 2025, Increases R&D Spending
Ivanhoe Electric Inc.Ivanhoe Electric Reports $17.5 Million Net Loss in Q3 2025, Revenue Declines